News and Trends 8 Sep 2022
First patient dosed in China trial with drug to treat non-Hodgkin lymphoma
The dosing of the first patient at a clinical trial in China for patients with relapsed/refractory non-Hodgkin lymphoma (NHL) was…
CASI Pharmaceuticals
- Latest Posts
News and Trends 11 Jul 2022
Financing round of $21M completed for drug to treat autoimmune diseases
The first-round of financing to the tune of $21 million (€20.6 million), for a drug to treat autoimmune disease, has…
